Ovid Therapeutics Inc.
Ovid Therapeutics Inc. (OVID) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · OVID · as of Jun 9, 2026
Activity summary
Buy transactions
4
P-Purchase only
Sell transactions
2
12 Months
Buy/Sell ratio
2.00
Buy/Sell (by trades)
Overall sentiment
Ovid Therapeutics Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
OVID insider buying and selling by quarter
OVID insider selling · OVID insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · OVID ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
OVID executive sell shares · OVID board member insider trading · OVID insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Apr 7, 2026 | PAPADOPOULOS STELIOS Director | Award | 17,578 | $45K | Form 4 |
| Apr 7, 2026 | Friedman Bart Director | Award | 8,789 | $22K | Form 4 |
| Apr 7, 2026 | Fitzgerald Kevin Joseph Director | Award | 17,578 | $45K | Form 4 |
| Mar 23, 2026 | LEVIN JEREMY M Executive Chairman · Director | Option | 47,333 | $66K | Form 4 |
| Feb 23, 2026 | ALEXANDER MARGARET A. President and CEO · Director | Sale | 11,656 | $17K | Form 4 |
| Feb 26, 2026 | Rona Jeffrey A CBFO | Award | 68,125 | — | Form 4 |
| Feb 23, 2026 | Rona Jeffrey A CBFO | Sale | 8,541 | $12K | Form 4 |
| Dec 15, 2025 | LEVIN JEREMY M CEO · Director | Other | 71,000 | — | Form 4 |
| Dec 8, 2025 | TAKEDA PHARMACEUTICAL CO LTD 10 percent owner | Other | 1,250,000 | — | Form 4 |
| Feb 26, 2025 | ALEXANDER MARGARET A. President and COO | Sale | 5,279 | $3K | Form 4 |
| Feb 26, 2025 | Rona Jeffrey A CBFO | Sale | 3,902 | $2K | Form 4 |
| Feb 20, 2025 | Rona Jeffrey A CBFO | Award | 43,750 | — | Form 4 |
| Feb 20, 2025 | ALEXANDER MARGARET A. President and COO | Award | 43,750 | — | Form 4 |
| Jan 27, 2025 | ALEXANDER MARGARET A. President and COO | Purchase | 6,810 | $5K | Form 4 |
| Mar 18, 2024 | LEVIN JEREMY M CEO · Director | Purchase | 18,248 | $50K | Form 4 |
| Feb 22, 2024 | Tardio Jason COO | Award | 28,125 | — | Form 4 |
| Feb 22, 2024 | Rona Jeffrey A CBFO | Award | 28,125 | — | Form 4 |
| Feb 22, 2024 | Perone Thomas Michael General Counsel, Secretary | Award | 28,125 | — | Form 4 |
| Dec 4, 2023 | LEVIN JEREMY M CEO · Director | Gift | 573,275 | — | Form 4 |
| Dec 4, 2023 | LEVIN JEREMY M CEO · Director | Gift | 573,275 | — | Form 4 |
| Sep 12, 2022 | Tardio Jason COO | Sale | 17,344 | $37K | Form 4 |
| Jul 1, 2022 | TAKEDA PHARMACEUTICAL CO LTD 10 percent owner | Other | 5,750,000 | — | Form 4 |
| Jul 1, 2022 | TAKEDA PHARMACEUTICAL CO LTD 10 percent owner | Other | 5,750,000 | — | Form 4 |
LEVIN JEREMY M
Executive Chairman · Director
Date
Mar 23
Shares
47,333
Price
$1.40
Value
$66K
ALEXANDER MARGARET A.
President and CEO · Director
Date
Feb 23
Shares
11,656
Price
$1.45
Value
$17K
TAKEDA PHARMACEUTICAL CO LTD
10 percent owner
Date
Dec 8
Shares
1,250,000
Price
—
Value
—
ALEXANDER MARGARET A.
President and COO
Date
Feb 26
Shares
5,279
Price
$0.56
Value
$3K
ALEXANDER MARGARET A.
President and COO
Date
Jan 27
Shares
6,810
Price
$0.73
Value
$5K
Perone Thomas Michael
General Counsel, Secretary
Date
Feb 22
Shares
28,125
Price
—
Value
—
TAKEDA PHARMACEUTICAL CO LTD
10 percent owner
Date
Jul 1
Shares
5,750,000
Price
—
Value
—
TAKEDA PHARMACEUTICAL CO LTD
10 percent owner
Date
Jul 1
Shares
5,750,000
Price
—
Value
—
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About OVID insider trading
OVID insider trades
Ovid Therapeutics Inc. (OVID) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including LEVIN JEREMY M (Executive Chairman · Director), Rona Jeffrey A (CBFO), PAPADOPOULOS STELIOS (Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. OVID insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Ovid Therapeutics Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
OVID insider trading · 5 questionsThe insiders of Ovid Therapeutics Inc. (OVID) include executives and directors such as LEVIN JEREMY M (Executive Chairman · Director), Rona Jeffrey A (CBFO), PAPADOPOULOS STELIOS (Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026